Accurate diagnosis is vital to identify both the origin of infection and its infectious stage. For example, if your tests for Lyme Borreliosis are negative, it does not mean that you are not sick. No, because first of all, the tests are not always fully accurate, and furthermore, as explained in the previous page, the body might not yet have produced antibodies that indicate the presence of the presence of the infection. It is therefore vital to look for other pathogens.
Previously Inefficient treatments
Dr. Jadin's optimal solution
Dr. Jadin's treatments consists of pulsatile and monthly therapy of bacteriostatic, to open the cells, and bactericidal, to kill what is inside. Both antibiotics are to be taken together. The combinations have to be alternated, never given continuously, and are never prescribed at low dosage. Dr. Jadin uses the maximum active dosage tolerated, and is administrated in poly chemotherapy, recommended by P. Giroud and H.Floch. (Dr. Jadin’s book page 217.)
The time taken for the germs to stack and multiply in the cytoplasm of a cell and make it burst takes more less a month. They are then released in the blood flow where they cannot survive. This new cellular crossover allows the smaller germs to grow bigger, by binary division. It is at that point that it is best to administer the first treatment with antibiotics. It empties the cell of its content by causing the rupture of the membrane. This first treatment allows the development process of the germ to start all over again, so that the antibiotics intake can be specifically provided at critical stages of development. This is why this treatment is so efficient, because now that we know the current stage of the germ’s evolution, we can administer antibiotics at the rate of evolution of the disease and strike the germs when they are most vulnurable. For each specifically timed stage, the treatment will last for 7 to 10 days, in order to follow the natural multiplication of the germs.
This treatment is extremely unique, and has proven extraordinary efficiency. Not only is the treatment calibrated based on the development cycle of the germs, but the use of this treatment also minimalizes the resistance of microbes against the antibiotics. This resistance is usually encountered in treatments that make use of a continuous intake of antibiotics at low dosage. This was Proven by Paul Giroud, through his studies and research on Rickettsia. The other main problem with the continuous intake of antibiotics, is that it invites the germs to mutate rapidly, and give birth to new super resistant germs. These germs are significantly harder to treat, and often take years to get rid of.
Another extremely unique and positive aspect of this treatment, is that the discontinuous intake of antibiotics, allows the intermodal rest for patients between treatments. This allows the patient to: recover from fatigue, get rid of the toxins that are produced by the decomposing germs, and the reparation of damaged tissues for the following treatment phase.
Important to note, is that the high dosage administered to patients, does not trespass the pharmaceutical security limit. The risks of secondary problems caused by the treatments are extremely rare, however one should not follow this treatment if suffering from renal insufficiency or pregnancy. In case of infants, it might discolorate the teeth to come.
Different stages of Lyme, typhus and typhus-like diseases imply different treatments. Early staged Lyme disease can according to the Centre of Disease Control and Prevention, be treated within 24 days using specific combinations of antibiotics that target the germs. The infection can be treated for both children and adult using similar methods. They say that "after the 24 days the patient should rapidly or fully recover from their infection and their associated symptoms" however, Dr. Jardin's research and experience has demonstrated that a very large portion of patients suffering from early staged Lyme disease are not cured using this recommended treatment. This short term treatments have been proven to be inefficient in 20 to 30% of cases for early staged Lyme, and for over 50% in late staged Lyme. There are several reasons why these treatments might not have functioned, but in most cases it means the treatment was not correctly adapted considering the following factors: age, weight, medical history, underlying health conditions, pregnancy status, or allergies.